Lobbying client
IPSEN
International specialty pharmaceutical company.
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$30,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2008 to 2010
Filings
7 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2010
|
REED SMITH LLP | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2009
|
REED SMITH LLP | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2009
|
REED SMITH LLP | — reported |
|
2nd Quarter - Report 2nd Quarter 2009
|
REED SMITH LLP | — reported |
|
1st Quarter - Report 1st Quarter 2009
|
REED SMITH LLP | — reported |
|
4th Quarter - Report 4th Quarter 2008
|
REED SMITH LLP | $30,000 reported |
|
Registration 4th Quarter 2008
|
REED SMITH LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| REED SMITH LLP | 6 | $30,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Foreign Relations | FOR | 4 |
| Intelligence | INT | 3 |
| Health Issues | HCR | 3 |
| Homeland Security | HOM | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.